Skip to main content
. 2020 Dec 19;14(2):103–116. doi: 10.4103/ajts.ajts_192_20

Table 2.

Distribution of adverse transfusion reactions year wise from 2013 to 2017

Adverse Reaction 2013-16* 2016 2017
Immunological Haemolysis due to other Allo-Antibodies 58 (1.49) 4 (0.31) 1 (0.03)
Allergic Reaction N/A** 456 (35.66) 1129 (37.89)
Anaphylaxis/Hypersensitivity 495 (12.68) 22 (1.72) 46 (1.54)
FNHTR 1594 (40.84) 627 (49) 1266 (42.5)
Hypotensive Transfusion Reaction 0 25 (1.95) 40 (1.34)
Immunological Haemolysis due to ABO Incompatibility 22 (0.56) 5 (0.4) 7 (0.23)
Non Immunological Haemolysis 84 (2.15) 6 (0.47) 20 (0.67)
Other Reactions 1476 (37.82) 57 (4.46) 255 (8.56)
TACO 26 (0.67) 14 (1.1) 40 (1.34)
TAD 93 (2.38) 47 (3.7) 153 (5.13)
Transfusion associated hypertension 0 0 1 (0.03)
PTP 25 (0.64) 0 0
TRALI 10 (0.25) 3 (0.23) 8 (0.27)
TAGvHD 1 (0.03) 0 0
Transfusion Transmitted Parasitical Infection (malaria) 1 (0.03) 0 0
TTBI 18 (0.46) 13 (1.00) 14 (0.47)
Total 3903 1279 2980

*Up to 30th April, 2016 before new Haemo-Vigil Software was launched. **Covered under Anaphylaxis/Hypersensitivity Category till 30th April, 2016 before new Haemo-Vigil Software was launched